Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration

被引:40
作者
Skopp, G [1 ]
Ganssmann, B [1 ]
Cone, EJ [1 ]
Aderjan, R [1 ]
机构
[1] NIDA,ADDICT RES CTR,NIH,BALTIMORE,MD 21224
关键词
D O I
10.1093/jat/21.2.105
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The disposition of heroin and its metabolites was investigated in four healthy male volunteers following intranasal administration of 6 and 12 mg heroin hydrochloride. In addition, two doses of 6 mg heroin hydrochloride were injected intramuscularly for comparison of pharmacokinetics parameters. Serum samples were analyzed for heroin, 6-acetylmorphine, and morphine by solid-phase extraction-gas chromatography-mass spectrometry. The concentration of morphine glucuronides was determined by high-performance liquid chromatography based on the native fluorescence of the conjugates. Major findings were rapidly rising and declining terminal phases for heroin and 6-acetylmorphine and slowly declining phases of morphine and metabolites after both routes of administration. The area under the curve values of morphine-3-glucuronide depended on dose but not on route of administration. The apparent terminal half-lives of morphine-3-glucuronide ranged from 2.2 to 5.2 h for intranasally administered heroin and were 3.0 and 1.7 h for the intramuscularly applied drug. A mean morphine-3-glucuronide-heroin:area- under-curve ratio of 93 for the intranasal route as compared with 38 for the intramuscular route demonstrated that circulating amounts of heroin were about half the size after intranasal administration of the same dose.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 34 条
[1]   MORPHINE AND MORPHINE GLUCURONIDES IN SERUM OF HEROIN CONSUMERS AND IN HEROIN-RELATED DEATHS DETERMINED BY HPLC WITH NATIVE FLUORESCENCE DETECTION [J].
ADERJAN, R ;
HOFMANN, S ;
SCHMITT, G ;
SKOPP, G .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1995, 19 (03) :163-168
[2]   SERUM MORPHINE CONCENTRATION AFTER ORAL-ADMINISTRATION OF DIAMORPHINE HYDROCHLORIDE AND MORPHINE-SULFATE [J].
AHERNE, GW ;
PIALL, EM ;
TWYCROSS, RG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :577-580
[3]   DISPOSITION OF MORPHINE AND ITS GLUCURONIDE METABOLITES AFTER ORAL AND RECTAL ADMINISTRATION - EVIDENCE OF ROUTE SPECIFICITY [J].
BABUL, N ;
DARKE, AC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (03) :286-292
[4]  
Baselt R.C., 1989, DISPOSITION TOXIC DR
[5]   METABOLISM OF MORPHINE AND HEROIN IN MAN [J].
BOERNER, U ;
ABBOTT, S ;
ROE, RL .
DRUG METABOLISM REVIEWS, 1975, 4 (01) :39-73
[6]   MORPHINE 6-GLUCURONIDE AND MORPHINE 3-GLUCURONIDE AS MOLECULAR CHAMELEONS WITH UNEXPECTED LIPOPHILICITY [J].
CARRUPT, PA ;
TESTA, B ;
BECHALANY, A ;
ELTAYAR, N ;
DESCAS, P ;
PERRISSOUD, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (04) :1272-1275
[7]   PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRANASAL SNORTED HEROIN [J].
CONE, EJ ;
HOLICKY, BA ;
GRANT, TM ;
DARWIN, WD ;
GOLDBERGER, BA .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1993, 17 (06) :327-337
[8]   PHARMACOKINETIC INTERPRETATION OF THE ENTEROHEPATIC RECIRCULATION AND 1ST-PASS ELIMINATION OF MORPHINE IN THE RAT [J].
DAHLSTROM, BE ;
PAALZOW, LK .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :505-519
[9]   AIDS AND INTRANASAL HEROIN [J].
FRENCH, JF ;
SAFFORD, J .
LANCET, 1989, 1 (8646) :1082-1082
[10]  
GIBALDI M, 1991, BIOPHARMACEUTICS CLI